Next Weeks Broker Price Targets For NewLink Genetics Corporation (NLNK)

Lloyd Doyle
October 16, 2017

The stock decreased 0.28% or $0.05 on October 13, reaching $18.05. Jacobs Levy Equity Mgmt has invested 0% in NewLink Genetics Corp (NASDAQ:NLNK). It has outperformed by 49.56% the S&P500. Segall Bryant & Hamill Limited Company reported 0.03% stake. The stock exchanged hands 3.58 Million shares versus average trading capacity of 2.54 Million shares. After $-0.57 actual earnings per share reported by NewLink Genetics Corp for the previous quarter, Wall Street now forecasts 40.35% negative EPS growth. The stock decreased 4.29% or $0.45 on October 13, reaching $10.05. About 146,795 shares traded. (NASDAQ:PLUS) has risen 75.66% since October 14, 2016 and is uptrending. It has outperformed by 33.20% the S&P500. That compares with the recent volume average of 0.6 million. Raytheon Company had 56 analyst reports since July 28, 2015 according to SRatingsIntel. Cantor Fitzgerald reiterated a "buy" rating and issued a $26.00 target price on shares of NewLink Genetics Corporation in a research note on Monday, September 25th. They now have a United States dollars 30 price target on the stock.

In other news, major shareholder Stine Seed Farm, Inc. bought 780,487 shares of the stock in a transaction on Friday, October 6th. The firm has "Hold" rating by Stifel Nicolaus given on Sunday, September 10. Jefferies has "Hold" rating and $7.0 target. The rating was downgraded by Sidoti to "Neutral" on Tuesday, November 15.

Analysts await ePlus Inc. Fifth Third Savings Bank invested in 0% or 1,000 shares. PLUS's profit will be $18.00M for 18.89 P/E if the $1.27 EPS becomes a reality. They expect $-0.80 EPS, down 48.15% or $0.26 from last year's $-0.54 per share.

Investors sentiment increased to 4.68 in 2017 Q2. Its down 2.40, from 3 in 2017Q1. 1 funds opened positions while 2 raised stakes. Citigroup reported 5,971 shares or 0% of all its holdings. Swiss Fincl Bank reported 35,700 shares. (NASDAQ:PLUS) for 23,628 shares. Wells Fargo Mn has 0% invested in Cohen & Company Inc (NYSEAMERICAN:COHN). (NASDAQ:PLUS) for 51,826 shares. Bridgeway Management holds 30,000 shares. 1,646 were accumulated by Mcf Advsr. (NASDAQ:PLUS) for 25,105 shares. Blackrock invested in 250,977 shares or 0% of the stock. Moreover, Jpmorgan Chase has 0% invested in ePlus Inc. Vertex Pharmaceuticals Inc (NASDAQ:VRTX) was reduced too. State Of Wisconsin Invest Board has 17,000 shares for 0% of their portfolio. Bessemer accumulated 0% or 13,700 shares. Ativo Cap Mngmt Ltd Com has invested 0.35% in ePlus Inc. Chesley Taft & Associate Ltd Co reported 0.48% in Raytheon Company (NYSE:RTN). (NASDAQ:PLUS) for 22,831 shares.

Equities research analysts at Bank of America Corporation started coverage on shares of NewLink Genetics Corporation (NASDAQ:NLNK) in a research note issued to investors on Friday. Therefore 100% are positive. Jefferies Group LLC lifted their price objective on NewLink Genetics Corp from $12.00 to $15.00 and gave the company a hold rating in a report on Wednesday, March 1st. Zacks Investment Research upgraded NewLink Genetics Corporation from a sell rating to a hold rating in a report on Saturday, July 29th. The brokerage set a "buy" rating and a $22.00 price target on the biotechnology company's stock. The rating was initiated by Robert W. Baird on Wednesday, March 23 with "Outperform". SunTrust upgraded NewLink Genetics Corp (NASDAQ:NLNK) rating on Thursday, March 30. On Monday, April 3 the stock rating was maintained by Credit Suisse with "Buy". As per Thursday, August 24, the company rating was maintained by Jefferies.

Shares of NewLink Genetics Corporation (NASDAQ NLNK) traded down 4.44% during midday trading on Friday, hitting $10.75. Stifel Nicolaus has "Buy" rating and $1400 target.

Investors sentiment decreased to 0.94 in 2017 Q2. Moreover, Endurant Cap Mngmt L P has 0.18% invested in NewLink Genetics Corp (NASDAQ:NLNK) for 84,598 shares.

A number of hedge funds have recently added to or reduced their stakes in NLNK. Newlink Genetics Corp now has $389.39M valuation.

Consequently Newlink Genetics Cor (NASDAQ:NLNK)'s weekly and monthly volatility is 7.44%, 10.19% respectively. Manufacturers Life Insurance The accumulated 0% or 19,069 shares. NewLink Genetics Corp has a one year low of $9.66 and a one year high of $25.17. Tudor Invest Corporation Et Al reported 38,916 shares. 591,765 are held by Columbus Circle Invsts. Proshare Advsrs Ltd Liability Company invested 0% in NewLink Genetics Corp (NASDAQ:NLNK). New York-based Pdts Partners Ltd has invested 0.03% in NewLink Genetics Corp (NASDAQ:NLNK).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article